Novartis AG Common Stock (NVS)
EBITDA Margin
40.01%
TTM · Period ending:
NVS EBITDA Margin
Latest reported40.01%period ending
Latest reported40.01%period ending
NVS TTM EBITDA Margin (2.46% → 40.01%)
TTM ebitda margin
High-resolution chart · PNG
NVS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 40.0105% | |
| 39.9617% | |
| 40.6432% | |
| 40.6869% | |
| 41.1499% | |
| 41.1146% | |
| 40.0507% | |
| 39.4654% | |
| 38.8457% | |
| 38.399% | |
| 39.1234% | |
| 37.4831% | |
| 36.0122% | |
| 33.8569% | |
| 32.0219% | |
| 61.1605% | |
| 60.3963% | |
| 62.2431% | |
| 62.5243% | |
| 35.8156% | |
| 35.3596% | |
| 34.6604% | |
| 34.4924% | |
| 33.7468% | |
| 33.1227% | |
| 32.2031% | |
| 32.0809% | |
| 30.6176% | |
| 30.9382% | |
| 43.0707% | |
| 42.8237% | |
| 44.3314% | |
| 43.6884% | |
| 28.5945% | |
| 25.3755% | |
| 23.8478% | |
| 23.7029% | |
| 26.148% | |
| 29.7334% | |
| 28.6799% | |
| 28.0385% | |
| 28.0568% | |
| 28.301% | |
| 31.0423% | |
| 32.878% | |
| 33.4703% | |
| 32.9231% | |
| 30.976% | |
| 29.1589% | |
| 29.2213% | |
| 28.758% | |
| 29.3347% | |
| 29.5178% | |
| 29.1942% | |
| 28.9241% | |
| 27.6175% | |
| 27.7341% | |
| 27.9806% | |
| 29.1571% | |
| 29.7011% | |
| 30.306% | |
| 30.2113% | |
| 30.6685% | |
| 31.603% | |
| 30.6639% | |
| 30.017% | |
| 28.3218% | |
| 29.2937% | |
| 29.7103% | |
| 29.9144% | |
| 30.1616% | |
| 27.8798% | |
| 27.7728% | |
| 27.2112% | |
| 27.1651% | |
| 29.6167% | |
| 29.0298% | |
| 29.3251% | |
| 29.2392% | |
| 29.8621% | |
| 29.8732% | |
| 29.454% | |
| 28.5829% | |
| 28.6751% | |
| 28.9151% | |
| 29.6971% | |
| 29.8616% | |
| 30.3551% | |
| 30.5062% | |
| 30.0287% | |
| 30.5421% | |
| 27.4683% | |
| 27.356% | |
| 26.7585% | |
| 41.4837% | |
| -9.7758% | |
| 9.7827% | |
| 8.0471% | |
| 6.0724% | |
| -0.3845% |